Dr. Hebbar of CalciMedica Talks Auxora Clinical Trial Targeting COVID-19, CRAC, and More| Podcast S2 E36

Companies To Watch: CalciMedica

Dozens of Houston’s sickest COVID-19 patients picked for trial of new drug that could reduce need for ventilator by 50 percent

FDA greenlights expansion of COVID-19 study to VCU Medical Center after positive data

VC Daily: Biotech Startups Ramp Up Funding and Fight Against Coronavirus; Companies Face New Privacy Ruling

Scroll to Top